![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Salvatore Stefano Serati Maurizio Bolis Pierfrancesco
Publisher: Informa Healthcare
ISSN: 1465-6566
Source: Expert Opinion on Pharmacotherapy, Vol.9, Iss.7, 2008-05, pp. : 1249-1255
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tolterodine for the treatment of overactive bladder: a review
Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 4, 2005-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tolterodine effective in the treatment of overactive bladder
Inpharma, Vol. 1, Iss. 1330, 2002-01 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Tolterodine: A Review of its Use in the Treatment of Overactive Bladder
Drugs & Aging, Vol. 18, Iss. 4, 2001-04 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Twelve-Month Treatment of Overactive Bladder: Efficacy and Tolerability of Tolterodine
By Abrams P.
Drugs & Aging, Vol. 18, Iss. 7, 2001-01 ,pp. :